S-nitrosylation of FLICE inhibitory protein determines its interaction with RIP1 and activation of NF-κB

Cell Cycle

Volumn 13, Issue 12, 2014, Pages 1948-1957

  Talbott, Siera Jo ^a   Luanpitpong, Sudjit ^a   Stehlik, Christian ^b   Azad, Neelam ^c   Iyer, Anand Krishnan V ^c   Wang, Liying ^d   Rojanasakul, Yon ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c HAMPTON UNIVERSITY   (United States)

^d NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Cancer; FLIP; NF B; RIP1; S nitrosylation

Indexed keywords

CYSTEINE; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PROTEIN KINASE; PROTEIN S; RECEPTOR INTERACTING PROTEIN KINASE 1; S NITROSOTHIOL; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; AGFG1 PROTEIN, HUMAN; NUCLEOPORIN; RNA BINDING PROTEIN;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; COVALENT BOND; EMBRYO; HEK293 CELL LINE; HUMAN; HUMAN CELL; MCF 7 CELL LINE; NITROSYLATION; POINT MUTATION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; GENETICS; METABOLISM; TUMOR CELL LINE;

CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL LINE, TUMOR; CYSTEINE; HUMANS; NF-KAPPA B; NITRIC OXIDE; NUCLEAR PORE COMPLEX PROTEINS; POINT MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA-BINDING PROTEINS; TNF RECEPTOR-ASSOCIATED FACTOR 2;

EID: 84902525796     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.28898     Document Type: Article

References (39)

1. Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene 1998; 17:3261-70; PMID:9916988; http://dx.doi.org/10.1038/ sj.onc.1202568
2. Debatin KM, Krammer PH. Death receptors in chemotherapy and cancer. Oncogene 2004; 23:2950-66; PMID:15077156; http://dx.doi.org/10.1038/sj.onc. 1207558
3. Budd RC. Death receptors couple to both cell proliferation and apoptosis. J Clin Invest 2002; 109:437-41; PMID:11854313; http://dx.doi.org/10.1172/ JCI0215077
4. Gibson SB, Oyer R, Spalding AC, Anderson SM, Johnson GL. Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL. Mol Cell Biol 2000; 20:205-12; PMID:10594023; http://dx.doi.org/10.1128/MCB.20.1.205-212.2000
5. Falschlehner C, Ganten TM, Koschny R, Schaefer U, Walczak H. TRAIL and other TRAIL receptor agonists as novel cancer therapeutics. Adv Exp Med Biol 2009; 647:195-206; PMID:19760076; http://dx.doi.org/10.1007/978-0-387-89520-8-14
6. Scaffidi C, Schmitz I, Krammer PH, Peter ME. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 1999; 274:1541-8; PMID:9880531; http://dx.doi.org/10.1074/jbc.274.3.1541
7. Thome M, Tschopp J. Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol 2001; 1:50-8; PMID:11905814; http://dx.doi.org/10.1038/ 35095508
8. Krueger A, Baumann S, Krammer PH, Kirchhoff S. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol Cell Biol 2001; 21:8247-54; PMID:11713262; http://dx.doi.org/10.1128/MCB.21.24.8247-8254.2001
9. Wajant H. Targeting the FLICE Inhibitory Protein (FLIP) in cancer therapy. Mol Interv 2003; 3:124-7; PMID:14993418; http://dx.doi.org/10.1124/mi. 3.3.124
10. Kataoka T, Tschopp J. N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway. Mol Cell Biol 2004; 24:2627-36; PMID:15024054; http://dx.doi.org/10.1128/MCB.24.7.2627-2636.2004
11. Dohrman A, Kataoka T, Cuenin S, Russell JQ, Tschopp J, Budd RC. Cellular FLIP (long form) regulates CD8+ T cell activation through caspase-8-dependent NF-kappa B activation. J Immunol 2005; 174:5270-8; PMID:15843523; http://dx.doi.org/10.4049/jimmunol.174.9.5270
12. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schröter M, Burns K, Mattmann C, et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388:190-5; PMID:9217161; http://dx.doi.org/10.1038/40657
13. Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, et al. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 2000; 10:640-8; PMID:10837247; http://dx.doi.org/10.1016/S0960-9822(00)00512-1
14. Sun Q, Zachariah S, Chaudhary PM. The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation. J Biol Chem 2003; 278:52437-45; PMID:14563855; http://dx.doi.org/10. 1074/jbc.M304199200
15. Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L. Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene 2000; 19:4451-60; PMID:11002417; http://dx.doi.org/10.1038/sj.onc.1203812
16. Golks A, Brenner D, Krammer PH, Lavrik IN. The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation. J Exp Med 2006; 203:1295-305; PMID:16682493; http://dx.doi.org/10.1084/jem.20051556
17. Kreuz S, Siegmund D, Scheurich P, Wajant H. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 2001; 21:3964-73; PMID:11359904; http://dx.doi.org/10.1128/MCB.21.12. 3964-3973.2001
18. Varfolomeev E, Goncharov T, Fedorova AV, Dynek JN, Zobel K, Deshayes K, Fairbrother WJ, Vucic D. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem 2008; 283:24295-9; PMID:18621737; http://dx.doi.org/10.1074/jbc.C800128200
19. Devin A, Cook A, Lin Y, Rodriguez Y, Kelliher M, Liu Z. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 2000; 12:419-29; PMID:10795740; http://dx.doi.org/10.1016/S1074-7613(00)80194-6
20. Geserick P, Hupe M, Moulin M, Wong WW, Feoktistova M, Kellert B, Gollnick H, Silke J, Leverkus M. Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol 2009; 187:1037-54; PMID:20038679; http://dx.doi.org/10.1083/jcb.200904158
21. Park S, Hatanpaa KJ, Xie Y, Mickey BE, Madden CJ, Raisanen JM, Ramnarain DB, Xiao G, Saha D, Boothman DA, et al. The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. Cancer Res 2009; 69:2809-16; PMID:19339267; http://dx.doi.org/10.1158/0008-5472.CAN-08-4079
22. Higuchi H, Yoon JH, Grambihler A, Werneburg N, Bronk SF, Gores GJ. Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis. J Biol Chem 2003; 278:454-61; PMID:12407100; http://dx.doi.org/10.1074/jbc.M209387200
23. Kaunisto A, Kochin V, Asaoka T, Mikhailov A, Poukkula M, Meinander A, Eriksson JE. PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability. Cell Death Differ 2009; 16:1215-26; PMID:19343040; http://dx.doi.org/10.1038/cdd.2009.35
24. Chanvorachote P, Nimmannit U, Wang L, Stehlik C, Lu B, Azad N, Rojanasakul Y. Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of FLICE inhibitory protein. J Biol Chem 2005; 280:42044-50; PMID:16246840; http://dx.doi.org/10.1074/jbc.M510080200
25. Marshall HE, Hess DT, Stamler JS. S-nitrosylation: physiological regulation of NF-kappaB. Proc Natl Acad Sci U S A 2004; 101:8841-2; PMID:15187230; http://dx.doi.org/10.1073/pnas.0403034101
26. Neumann L, Pforr C, Beaudouin J, Pappa A, Fricker N, Krammer PH, Lavrik IN, Eils R. Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Mol Syst Biol 2010; 6:352; PMID:20212524; http://dx.doi.org/10.1038/msb.2010.6
27. Bijangi-Vishehsaraei K, Saadatzadeh MR, Huang S, Murphy MP, Safa AR. 4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide (CMH) targets mRNA of the c-FLIP variants and induces apoptosis in MCF-7 human breast cancer cells. Mol Cell Biochem 2010; 342:133-42; PMID:20446019; http://dx.doi.org/10.1007/s11010- 010-0477-7
28. Sánchez-Pérez T, Ortiz-Ferrón G, López-Rivas A. Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by anti-microtubule agents. Cell Death Differ 2010; 17:883-94; PMID:19942932; http://dx.doi.org/10.1038/cdd.2009.176
29. Luo A, Wang W, Sima N, Lu Y, Zhou J, Xu G, Yu H, Wang S, Ma D. Short hairpin RNA targeting c-FLIP sensitizes human cervical adenocarcinoma Hela cells to chemotherapy and radiotherapy. Cancer Lett 2008; 271:323-32; PMID:18675507; http://dx.doi.org/10.1016/j.canlet.2008.06.026
30. Wilson TR, McEwan M, McLaughlin K, Le Clorennec C, Allen WL, Fennell DA, Johnston PG, Longley DB. Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in type II colorectal cancer cells. Oncogene 2009; 28:63-72; PMID:18820704; http://dx.doi.org/10.1038/onc.2008.366
31. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 2001; 276:20633-40; PMID:11279218; http://dx.doi.org/10.1074/jbc.M101780200
32. Marshall HE, Stamler JS. Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 2001; 40:1688-93; PMID:11327828; http://dx.doi.org/10.1021/ bi002239y
33. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 1998; 8:297-303; PMID:9529147; http://dx.doi.org/10.1016/S1074-7613(00)80535-X
34. Schütze S, Tchikov V, Schneider-Brachert W. Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat Rev Mol Cell Biol 2008; 9:655-62; PMID:18545270; http://dx.doi.org/10.1038/nrm2430
35. Park SJ, Kim YY, Ju JW, Han BG, Park SI, Park BJ. Alternative splicing variants of c-FLIP transduce the differential signal through the Raf or TRAF2 in TNF-induced cell proliferation. Biochem Biophys Res Commun 2001; 289:1205-10; PMID:11741321; http://dx.doi.org/10.1006/bbrc.2001.6086
36. Kim DJ, Park C, Oh B, Kim YY. Association of TRAF2 with the short form of cellular FLICE-like inhibitory protein prevents TNFR1-mediated apoptosis. J Mol Signal 2008; 3:2; PMID:18190721; http://dx.doi.org/10.1186/1750-2187-3-2
37. Tannenbaum SR, White FM. Regulation and specificity of S-nitrosylation and denitrosylation. ACS Chem Biol 2006; 1:615-8; PMID:17168564; http://dx.doi.org/10.1021/cb600439h
38. Sharp DA, Lawrence DA, Ashkenazi A. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J Biol Chem 2005; 280:19401-9; PMID:15760909; http://dx.doi.org/10.1074/jbc.M413962200
39. Birbach A, Gold P, Binder BR, Hofer E, de Martin R, Schmid JA. Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus. J Biol Chem 2002; 277:10842-51; PMID:11801607; http://dx.doi.org/10. 1074/jbc.M112475200